Cover Image

Cost-Effectiveness Analysis of Triple Combination Preparations in the Treatment of Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Objectives: This study analyzed the long-term cost-effectiveness of fluticasone/umeclidinium/vilanterol triple combination (FF/UMEC/VI) vs. budesonide/formoterol double combination (BUD/FOR) in the treatment of moderate-to-severe chronic obstructive pulmonary disease (COPD) and provides evidence for...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yikang Zhou (Author), Enwu Long (Author), Qian Xu (Author), Lei Wang (Author), Xuehua Jiang (Author), Ming Hu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
by: Eklund O, et al.
Published: (2016)

Assessment of Health-Related Quality of Life Using EuroQoL-5 Dimension in Populations With Prediabetes, Diabetes, and Normal Glycemic Levels in Southwest China
by: Enwu Long, et al.
Published: (2021)

Effects of modified pulmonary rehabilitation on patients with moderate to severe chronic obstructive pulmonary disease: A randomized controlled trail
by: Jingjuan Xu, et al.
Published: (2017)

Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary disease
by: Jennifer Cook, et al.
Published: (2021)

"Triple duodenal obstruction" complicated with intestinal malrotation and several cardiovascular malformations
by: Masataka Takahashi, et al.
Published: (2021)

The Effectiveness of 3 Combined Therapeutic Regimens in Egyptian Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Randomized Double-Blind Prospective Pilot Study
by: Tarek M. Mostafa, et al.
Published: (2021)

Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India
by: Parvaiz A. Koul, et al.
Published: (2019)

Clinical predictors of moderate-to-severe pediatric obstructive sleep apnea
by: Kantarakorn Unchiti, et al.
Published: (2024)

Analysis the cost of chronic obstructive pulmonary disease in Russian Federation
by: I. S. Krysanov
Published: (2018)

Clinical Practice Guidelines for Severe Chronic Obstructive Pulmonary Disease.
by: Niurka Mercedes Galende Hernández, et al.
Published: (2009)

Clinical Practice Guidelines for Severe Chronic Obstructive Pulmonary Disease.
by: Niurka Mercedes Galende Hernández, et al.
Published: (2009)

Effect of Pulmonary Rehabilitation Program on Severity of Symptoms in Patients with Chronic Obstructive Pulmonary Disease
by: Sahar Khoshkesht, et al.
Published: (2015)

The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease
by: Sevket Ozkaya, et al.
Published: (2011)

Erectile dysfunction in male patients with severe chronic obstructive pulmonary disease
by: Hamdy M Hasan, et al.
Published: (2017)

Effect of abdominal binder on physiological cost index in chronic obstructive pulmonary disease
by: Chaitali Kadam, et al.
Published: (2021)

Efficacy and safety of photodynamic therapy combined with oral isotretinoin in the treatment of moderate to severe acne
by: Shujuan ZHANG, et al.
Published: (2024)

Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension
by: Wenxing Dong, et al.
Published: (2023)

Highly Monodisperse Chitosan Nanoparticles Prepared by a Combined Triple-Method for Potential Use as Drug Carriers
by: Mahya Safarzadeh, et al.
Published: (2017)

Efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease and obstructive sleep apnea; a randomized controlled trial
by: Honghua Shen, et al.
Published: (2024)

Allergy immunotherapy in combination with biological therapy in moderate and severe asthma
by: Dariya S. Kulichenko, et al.
Published: (2023)

Severe persistent pulmonary hypertension in a neonate with Rubinstein-Taybi syndrome accompanied by triple X syndrome
by: Chie Matsuguma, et al.
Published: (2022)

Interaction of Depression and Nicotine Addiction on the Severity of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study
by: Peian LOU, et al.
Published: (2016)

Relationship between disease severity and atrial fibrillation in chronic obstructive pulmonary disease
by: Ekrem Şahan, et al.
Published: (2021)

Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
by: Shalini Naik, et al.
Published: (2010)

The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease
by: Roberts MH, et al.
Published: (2015)

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update
by: Dal Negro RW, et al.
Published: (2015)

Pediatric Sleep Questionnaire Predicts Moderate-to-Severe Obstructive Sleep Apnea in Children and Adolescents with Obesity
by: Giuseppina Rosaria Umano, et al.
Published: (2022)

Combining hypertension and chronic obstructive pulmonary disease: clinical features and approaches to treatment
by: Roman Volodymyrovych Hnizdyukh, et al.
Published: (2017)

Combining hypertension and chronic obstructive pulmonary disease: clinical features and approaches to treatment
by: Roman Volodymyrovych Hnizdyukh, et al.
Published: (2017)

Relation of elastic properties of pulmonary artery with left ventricular abnormalities and aortic stiffness in patients with moderate to severe obstructive sleep apnea: A cross-sectional echocardiographic study
by: İbrahim Halil Altıparmak, et al.
Published: (2016)

Protective effects of simvastatin and/or telmisartan on cardiovascular system in patients with mild to moderate chronic obstructive pulmonary disease (COPD).
by: Ali M. H., et al.
Published: (2012)

Adalimumab in the treatment of moderate-severe hidradenitis suppurativa: a cost-effectiveness analysis
by: Sofia Borges, et al.
Published: (2018)

Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review
by: Spyratos D, et al.
Published: (2015)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
by: Chung-Yu Chen, et al.
Published: (2021)

Factors related to self-management behavior among persons with mild-to-moderate chronic obstructive pulmonary disease in Wenzhou, China
by: Sheng Xiao-Wen, et al.
Published: (2023)

Retraction notice to 'Effects of modified pulmonary rehabilitation on patients with moderate to severe chronic obstructive pulmonary disease: A randomized controlled trail' [IJNSS Volume 4, Issue 3, 10 July 2017, Pages 219-224]
by: Jingjuan Xu, et al.
Published: (2022)

Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain
by: Darbà J, et al.
Published: (2017)

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
by: Johansson E, et al.
Published: (2018)

A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
by: Giorgio L Colombo, et al.
Published: (2009)

Apremilast and NB-UVB combination therapy in moderate-to-severe plaque type psoriasis
by: O. Yu Olisova, et al.
Published: (2020)